MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Sun Pharma Inks deal with Chinese Pharmaceutical Company

Sun Pharma Inks deal with Chinese Pharmaceutical Company

Sun Pharmaceutical Industries, a Mumbai-based pharmaceutical company, has inked a deal with the subsidiary of China Medical System Holdings, a Chinese pharmaceutical company, ET reported.

The new licensing agreement will pave the way for Sun Pharma to work on the development and commercialization of dermatology products in Greater China, mainland China, Taiwan and special administrative regions of Hong Kong and Macau. The range of products for Sun Pharma includes Tildrakizumab, a biologic product for treating psoriatic arthritis and psoriasis along with an eye drop called Cyclosporine A 0.09 percent.

As per ET reports, The Chinese company will seal the deal initially with an upfront payment, royalties on net sales, sales milestones payments. The terms were not revealed by any of the companies.

The agreement will last for a period of 15 years from the first commercial sale of the two products in Greater China. And later on, the tenure may be increased to 3 years subject to specific conditions mentioned in the deal papers.

According to Sun Pharma, the new deal will help the company to enter the second largest pharmaceutical market in the world. The company is committed to expanding its dermatology franchises, with Tildrakizumab as its main product. The companycontinues to develop its therapeutic area of significant unmet need.

The new development will give confidence to other Pharmaceutical companies in India.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED